Joseph Kattan

3.6k total citations
207 papers, 2.0k citations indexed

About

Joseph Kattan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Joseph Kattan has authored 207 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Oncology, 87 papers in Pulmonary and Respiratory Medicine and 43 papers in Surgery. Recurrent topics in Joseph Kattan's work include Colorectal Cancer Treatments and Studies (21 papers), Cancer Treatment and Pharmacology (20 papers) and Lung Cancer Treatments and Mutations (17 papers). Joseph Kattan is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Cancer Treatment and Pharmacology (20 papers) and Lung Cancer Treatments and Mutations (17 papers). Joseph Kattan collaborates with scholars based in Lebanon, France and United States. Joseph Kattan's co-authors include Elie Rassy, Tarek Assi, Marwan Ghosn, Fadi Farhat, Hampig Raphaël Kourié, Jean‐Pierre Droz, Fadi El Karak, Georges Chahine, Fadi Farhat and Aline Hajj and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Joseph Kattan

182 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Kattan Lebanon 23 892 664 319 273 210 207 2.0k
Lucìa Mangone Italy 22 1.3k 1.4× 484 0.7× 345 1.1× 289 1.1× 373 1.8× 96 2.1k
Eva Segelov Australia 25 1.4k 1.6× 419 0.6× 375 1.2× 417 1.5× 218 1.0× 158 2.4k
Reda Wilson United States 20 985 1.1× 460 0.7× 422 1.3× 258 0.9× 375 1.8× 42 2.3k
Jane Bryce Italy 19 978 1.1× 408 0.6× 355 1.1× 175 0.6× 151 0.7× 41 1.8k
Patricia M. Jamison United States 13 1.4k 1.5× 505 0.8× 410 1.3× 307 1.1× 397 1.9× 19 2.5k
M J Quinn United Kingdom 24 1.1k 1.3× 655 1.0× 210 0.7× 498 1.8× 192 0.9× 40 2.2k
Hugues Bourgeois France 20 1.4k 1.6× 429 0.6× 305 1.0× 384 1.4× 415 2.0× 101 2.1k
Daniela Pierannunzio Italy 10 787 0.9× 364 0.5× 159 0.5× 303 1.1× 153 0.7× 18 1.6k
A. Verdecchia Italy 16 922 1.0× 492 0.7× 167 0.5× 413 1.5× 176 0.8× 31 1.9k
Nora Pashayan United Kingdom 25 811 0.9× 384 0.6× 206 0.6× 104 0.4× 186 0.9× 104 2.1k

Countries citing papers authored by Joseph Kattan

Since Specialization
Citations

This map shows the geographic impact of Joseph Kattan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Kattan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Kattan more than expected).

Fields of papers citing papers by Joseph Kattan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Kattan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Kattan. The network helps show where Joseph Kattan may publish in the future.

Co-authorship network of co-authors of Joseph Kattan

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Kattan. A scholar is included among the top collaborators of Joseph Kattan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Kattan. Joseph Kattan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kourié, Hampig Raphaël, Lewis Nasr, Fadi El Karak, et al.. (2024). Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer. Clinics and Research in Hepatology and Gastroenterology. 48(8). 102417–102417. 1 indexed citations
2.
3.
Kourié, Hampig Raphaël, Éliane Chouery, Cybel Mehawej, et al.. (2023). Genetic Polymorphisms Involved in Bladder Cancer: A Global Review. Oncology Reviews. 17. 10603–10603. 3 indexed citations
4.
Ghosn, Marwan, Joseph Kattan, Fadi El Karak, et al.. (2023). Renal cell carcinoma management: real-world practice and challenges at a national level. Future Oncology. 19(12). 863–872. 2 indexed citations
5.
Macaron, Walid, et al.. (2022). Palbociclib and letrozole in hormone-receptor positive advanced breast cancer: Predictive response and prognostic factors. Current Problems in Cancer. 46(3). 100859–100859. 9 indexed citations
6.
Rassy, Elie, Stergios Boussios, Tarek Assi, et al.. (2022). Sarcoma of unknown primary: myth or reality?. Journal of the Egyptian National Cancer Institute. 34(1). 27–27. 3 indexed citations
7.
Ibrahim, Tony, Elie Rassy, Fadi El Karak, et al.. (2020). Comprehensive tumor profiling-guided therapy in rare or refractory solid cancer: A feasibility study in daily clinical practice. Bulletin du Cancer. 107(4). 410–416.
8.
Farhat, Fadi, Bassim Al Bahrani, Eman Sbaity, et al.. (2020). Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries. World Journal of Clinical Cases. 8(3). 487–503. 5 indexed citations
9.
10.
Kourié, Hampig Raphaël, et al.. (2016). Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon.. PubMed. 17(5). 2679–81. 14 indexed citations
11.
Ghorra, Claude, et al.. (2016). Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon.. PubMed. 17(5). 2579–81. 1 indexed citations
12.
Assi, Tarek, Elie Rassy, Samer Tabchi, et al.. (2015). Treatment of cancer patients in their last month of life: aimless chemotherapy. Supportive Care in Cancer. 24(4). 1603–1608. 24 indexed citations
13.
Ghosn, Marwan, Carla Hajj, Joseph Kattan, et al.. (2011). Triple-Negative Breast Cancer in Lebanon: A Case Series. The Oncologist. 16(11). 1552–1556. 10 indexed citations
14.
15.
Lhommé, Catherine, et al.. (1997). Cisplatin-Based Chemotherapy in the Management of Germ Cell Tumors of the Ovary: The Institut Gustave Roussy Experience. Gynecologic Oncology. 64(1). 160–165. 16 indexed citations
16.
Culine, Stéphane, Catherine Lhommé, Joseph Kattan, et al.. (1995). Cisplatin-Based Chemotherapy in Dysgerminoma of the Ovary: Thirteen-Year Experience at the Institut Gustave Roussy. Gynecologic Oncology. 58(3). 344–348. 20 indexed citations
17.
Culine, Stéphane, et al.. (1994). [Carcinoma in situ of the testis].. PubMed. 81(3). 122–123.
18.
Droz, Jean‐Pierre, Joseph Kattan, F. Keuppens, et al.. (1994). Phase I trial of high‐dose fosfestrol in hormone‐refractory adenocarcinoma of the prostate. The Prostate. 24(2). 62–66. 10 indexed citations
19.
Kattan, Joseph, M F Tournade, Stéphane Culine, M.-J. Terrier-Lacombe, & Jean‐Pierre Droz. (1994). Adult Wilms' tumour: Review of 22 cases. European Journal of Cancer. 30(12). 1778–1782. 38 indexed citations
20.
Mahjoubi, M., et al.. (1992). Phase II trial of pirarubicin in the treatment of advanced bladder cancer. Investigational New Drugs. 10(4). 317–321. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucìa Mangone Breakdown of academic impact, for papers by Eva Segelov Breakdown of academic impact, for papers by Reda Wilson Breakdown of academic impact, for papers by Jane Bryce Breakdown of academic impact, for papers by Patricia M. Jamison Breakdown of academic impact, for papers by M J Quinn Breakdown of academic impact, for papers by Hugues Bourgeois Breakdown of academic impact, for papers by Daniela Pierannunzio Breakdown of academic impact, for papers by A. Verdecchia Breakdown of academic impact, for papers by Nora Pashayan
Rankless by CCL
2026